The HHS Secretary declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic.
American Society of Hematology. (2022).
Emergency Use Authorization: Drugs and Non-Vaccine Biological Products.
Retrieved from https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/emergency-use-authorization-drugs-and-non-vaccine-biological-products.
American Society of Hematology.
"Emergency Use Authorization: Drugs and Non-Vaccine Biological Products." Hematology.org.
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/emergency-use-authorization-drugs-and-non-vaccine-biological-products
(label-accessed October 11, 2024).
"American Society of Hematology."
Emergency Use Authorization: Drugs and Non-Vaccine Biological Products, 11 Oct. 2024 ,
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/emergency-use-authorization-drugs-and-non-vaccine-biological-products.
